ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
20 hedge funds and large institutions have $7.68M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.57M | |
| 2 | +$116K | |
| 3 | +$85.4K | |
| 4 |
Morgan Stanley
New York
|
+$30K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.94K |
Top Sellers
| 1 | -$12K | |
| 2 | -$7.74K | |
| 3 | -$6.45K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.35K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$966 |